Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-06-21
2005-06-21
Shameem, Golam M M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S333500
Reexamination Certificate
active
06908940
ABSTRACT:
Imidazole compounds having adenosine deaminase inhibitory activity represented by the formula (I) wherein R1is aryloxy, or aryl which is optionally substituted with suitable substituent(s); R2is lower alkyl; R3is hydroxy or protected hydroxy; and -A- is lower alkylene, its prodrug, or their salt. The compounds are useful for treating and/or preventing diseases for which adenosine is effective.
REFERENCES:
patent: 5866571 (1999-02-01), Niewohner et al.
patent: 6124303 (2000-09-01), Pamukcu et al.
patent: 6359145 (2002-03-01), Terasaka et al.
patent: 6596738 (2003-07-01), Terasaka et al.
patent: 98 02166 (1998-01-01), None
patent: 00 05217 (2000-02-01), None
patent: 00 55155 (2000-09-01), None
G. Cristalli et al.: “Adenosine deaminase Inhibitors: structure-activity relationships in 1-deazaadenosine and erythro-9-(2-hydroxy-3-nonyl)adenine analogs” Drug Development Research, vol. 28, no. 3, pp. 253-258.
G. Cristalli et al.: “Adenosine deaminase inhibitors: synthesis and structure-activity relationships of imidazole analogues of erythro-9-(2-hydroxy-3-nonyl)adenine” Journal of Medical Chemistry, vol. 34, no. 3, pp. 1187-1192 Mar. 1991.
C. Vargeese et al.: “Adenosine deaminase inhibitors, Synthesis and biological evaluation of putative metabolites of (+)-erythro-9-(2H-hydroxy-3R-nonyl) adenine” Journal of Medical Chemistry, vol. 37, no. 22, pp. 2844-2849 1994.
Nakamura Katsuya
Terasaka Tadashi
Tsuji Kiyoshi
Fujisawa Pharmaceutical Co. Ltd.
Oblon & Spivak, McClelland, Maier & Neustadt P.C.
Shameem Golam M M
LandOfFree
Imidazole compounds and their use as adenosine deaminase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole compounds and their use as adenosine deaminase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole compounds and their use as adenosine deaminase... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3514581